Activity and mechanisms of action of novel organosulfur derivatives of the HDAC inhibitor Valproic Acid in human experimental models of non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) represents the leading cause of cancer death worldwide, and 5-year survival is about 16% for patients diagnosed with advanced lung cancer and about 70-90% when the disease is diagnosed and treated at earlier stages. Treatment of NSCLC is changed in the last years...

Full description

Bibliographic Details
Main Author: Ulivi, Paola <1975>
Other Authors: Cantelli Forti, Giorgio
Format: Doctoral Thesis
Language:en
Published: Alma Mater Studiorum - Università di Bologna 2014
Subjects:
Online Access:http://amsdottorato.unibo.it/6310/